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Impact of intrauterine fetal 
resuscitation with oxygen 
on oxidative stress 
in the developing rat brain
Jia Jiang1,4, Tusar Giri1, Nandini Raghuraman2, Alison G. Cahill3 & Arvind Palanisamy1,2*
Use of maternal oxygen for intrauterine resuscitation is contentious because of the lack of evidence 
for its efficacy and the possibility of fetal harm through oxidative stress. Because the developing 
brain is rich in lipids and low in antioxidants, it remains vulnerable to oxidative stress. Here, we 
tested this hypothesis in a term pregnant rat model with oxytocin-induced fetal distress followed by 
treatment with either room air or 100% oxygen for 6 h. Fetal brains from both sexes were subjected 
to assays for biomarkers of oxidative stress (4-hydroxynonenal, protein carbonyl, or 8-hydroxy-
2ʹ-deoxyguanosine), expression of genes mediating oxidative stress, and mitochondrial oxidative 
phosphorylation. Contrary to our hypothesis, maternal hyperoxia was not associated with increased 
biomarkers of oxidative stress in the fetal brain. However, there was significant upregulation of 
the expression of select genes mediating oxidative stress, of which some were male-specific. These 
observations, however, were not accompanied by changes in the expression of proteins from the 
mitochondrial electron transport chain. In summary, maternal hyperoxia in the setting of acute 
uteroplacental ischemia-hypoxia does not appear to cause oxidative damage to the developing brain.
Maternal oxygen administration is one of the most widely practiced interventions for intrauterine resuscitation 
of a distressed  fetus1–5. However, whether such an intervention improves fetal or neonatal outcomes is question-
able. Recent meta-analyses suggest that maternal oxygen does not improve either fetal oxygenation or acid–base 
 status3,5. In addition, recent evidence from a randomized controlled trial suggested that room air resuscitation 
was non-inferior to oxygen therapy in the management of labor with Category II fetal heart rate  tracing6. Taken 
together with the added concern that maternal oxygen therapy and the relative hyperoxic environment could 
increase plasma biomarkers of oxidative stress during  delivery4,7,8, it is plausible that oxygen might be harmful 
rather than helpful. An unanswered question in this regard is whether the oxidative stress affects the develop-
ing fetal brain. This is important because the fetal brain is rich in lipids and low in antioxidants which could 
make it vulnerable to the effects of oxidative  stress9,10. A meaningful inquiry in human subjects, however, is not 
possible because of ethical limitations. To address this knowledge gap, we utilized our pragmatic term pregnant 
rat model designed to induce fetal distress by stimulating aberrant uterine contractility with oxytocin (OXT) 
11. Using this model, we investigated the effect of fetal resuscitation with either room air or 100% oxygen with 
the hypothesis that resuscitation with oxygen, compared to room air, would increase oxidative stress in the fetal 
brain. Furthermore, considering the sex-differences in the response to oxidative  stress12–16, we speculated that 
the male brain would be especially vulnerable.
Results
Dams from both room air and oxygen groups tolerated the experiment and all pups were noted to be alive at 
the time of cesarean delivery. The number of dams per treatment condition and their litter data are shown in 
Table 1. We first assessed whether maternal hyperoxia was associated with increased fetal oxygenation. Maternal 
exposure to 100% oxygen was associated with a significant increase in the  PaO2 and oxygen content of fetal left 
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ventricular blood (Table 2 and Fig. 1). However, there were no significant differences in the pH,  paCO2,  HCO3, 
base deficit, or lactate levels between the two groups.  
We then assessed whether fetal resuscitation with maternal oxygen induces oxidative damage in the devel-
oping brain using validated biomarkers of oxidative stress (Fig. 2). We did not observe either treatment- or 
sex-specific differences in the concentration of 4-HNE, protein carbonyl, and 8-OHdG in the fetal cortex 
(Fig. 2A–C). Similarly, the magnitude of the antioxidant response, assessed with GSSG/GSH ratio was also no 
different between the treatment conditions of either fetal sex (Fig. 2D).
We next examined the impact of fetal resuscitation with oxygen on the differential expression of genes 
associated with oxidative stress and mitochondrial oxidative phosphorylation in the developing brain of both 
sexes (Fig. 3). Unlike the oxidative stress biomarkers, we observed a significant upregulation in the expression 
of genes mediating oxidative stress (Ucp3, Nox1), antioxidant response (Sod3, Cat, Prdx3, Txnrd2) and oxidative 
Table 1.  Details of animal use. One male and female pup/unique dam/treatment condition was used for 





(100%  O2) P value
E 20 dams 8 8
Litter size (mean ± S.D) 10.6 ± 2.4 11.4 ± 1.8 0.48
Sex of the pups (mean ± S.D.)
M 4.5 ± 2.3 5.5 ± 1.8 0.35
F 6.1 ± 1.8 5.9 ± 1.6 0.77
Survival 100% 100%
Table 2.  Blood gas analysis of the pups after in utero exposure to maternal hyperoxia. Left ventricular blood 
from three pups/unique dam/treatment condition was pooled prior to blood gas analysis, with the dam 
considered as the experimental unit. *p ≤ 0.05; **p ≤ 0.01
RA (n = 3) 100%  O2 (n = 3) p-value
pH 7.1 ± 0.04 7.2 ± 0.07 0.28
pO2 (mmHg) 33 ± 2.6 86 ± 12 0.02*
pCO2 (mmHg) 71 ± 7.3 55 ± 6.8 0.14
HCO3 (mmol/L) 22 ± 0.18 21 ± 1.7 0.71
Lactate (mmol/L) 12 ± 0.7 14 ± 1.1 0.21
Base excess (mmol/L) − 8.2 ± 0.72 − 9.7 ± 1.4 0.41
O2 content (mL/dL) 6.3 ± 1.3 13 ± 0.73 0.006**
Figure 1.  Maternal hyperoxia is associated with increased fetal oxygenation. Scatter plots showing the extent 
of increase in fetal  PaO2 (A) and oxygen content (B) after maternal hyperoxia with 100% oxygen for 6 h. Data 
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phosphorylation (Mt-cyb) in the developing brain after oxygen exposure (Fig. 3A). Among these genes, Nox1, 
Sod3, Cat, Prdx3, and Txnrd2 were differentially upregulated in the male vs. female brain after resuscitation with 
oxygen (Fig. 3B).
Considering our previous work showing changes in mitochondrial biogenesis after acute intrapartum 
 hypoxemia11, we were interested in understanding the additive impact of maternal administration of oxygen 
on mitochondrial oxidative phosphorylation. There were neither treatment nor sex-related differences in the 
expression of proteins related to any of the mitochondrial electron transport chain complexes in the maternal 
hyperoxia group (Fig. 4).
Discussion
Our investigations in a term pregnant rat model show that maternal hyperoxia in the setting of induced fetal 
distress did not appear to be associated with oxidative damage to the developing brain. Though we observed male 
sex-specific upregulation of select genes mediating oxidative stress and antioxidant defense, this was not accom-
panied by any changes in the mitochondrial proteins involved in the oxidative phosphorylation pathway. Taken 
together with our previous data showing a significant effect of acute uteroplacental ischemia on oxidative stress 
and behavioral outcomes even with room air  treatment11, our results suggest that the magnitude of the initial 
hypoxemic insult is more likely to impact outcomes rather than the choice of oxygen or room air resuscitation.
Our targeted preclinical research provides important novel data on oxidative stress in the fetal brain during 
intrauterine resuscitation with maternal oxygen after placental ischemia-hypoxemia. Though maternal hyperoxia 
is known to increase biomarkers of oxidative stress in the umbilical cord  blood7,17, it is unclear whether the puta-
tive oxidative stress affects the fetal brain, arguably the most important organ of interest. By adopting a pragmatic 
model of acute, reversible uteroplacental ischemia caused by oxytocin-induced aberrant uterine contractility, our 
studies were designed to reflect a relatively common and clinically relevant scenario during labor. The absence 
Figure 2.  Oxidative stress biomarkers in the fetal brain after maternal hyperoxia. Scatter plots showing the 
extent of oxidative damage to lipids, proteins, and DNA as quantified by 4-hydroxynonenal (A), protein 
carbonyl (B), and 8-OHdG (C), respectively. Maternal hyperoxia was not associated with an increase in any 
of the biomarkers in either sex. The GSSG/GSH ratio (D), indicative of the collective glutathione antioxidant 
response, was no different between the groups. Data are presented as mean ± S.E.M and analyzed with 2-way 
ANOVA with Sidak’s multiple comparisons test to assess for sex differences in the treated group (n = 8 male and 
female pups from 8 unique dams/treatment condition).
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Figure 3.  Differentially expressed oxidative stress genes in the fetal brain after maternal hyperoxia. (A) Scatter 
plots showing differential expression of genes involved in the oxidative stress response and prevention after 
maternal hyperoxia. There was a significant effect of treatment for Ucp3 ([F (1, 24) = 5.7]) and Mt-cyb ([F (1, 
20) = 5.06]), and a significant treatment vs. sex interaction for Nox1 ([F (1, 22) = 4.32]), Sod3 ([F (1, 21) = 5.5]), 
Cat ([F (1, 23) = 7.79]), Prdx3 ([F (1, 21) = 4.46]), and Txnrd2 ([F (1, 23) = 4.76]). (B) Bar graphs highlighting 
the sex-dependent differences in gene expression involving oxidative stress (left) and antioxidant defense (right) 
after maternal hyperoxia with 100% oxygen (ETC: electron transport chain). Data are presented as mean ± S.E.M 
and analyzed with 2-way ANOVA with Sidak’s multiple comparisons test to assess for sex differences in the 
treated group; *p ≤ 0.05 and **p ≤ 0.01 (n = 7 male and female pups from 7 unique dams/treatment condition).
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of oxidative damage in the fetal brain after maternal hyperoxia was contrary to our hypothesis. This unexpected 
result could partly be explained by dynamic changes in fetal cerebral blood flow and oxygenation during acute 
ischemia-hypoxia. For example, acute hypoxemia followed by reperfusion and a relatively hyperoxic environment 
is likely to result in enhanced oxidative stress. So, what could protect the fetal brain from maternal hyperoxia? 
Preserved ‘brain-sparing’ blood flow in a previously uncompromised fetus could reduce the fetal brain impact of 
acute uteroplacental ischemia and minimize oxidative stress by reducing the magnitude of initial  hypoxemia18. 
Conversely, it is equally plausible that oxygen delivery to the brain is not significantly enhanced after maternal 
hyperoxia, thereby limiting the generation of oxygen free radicals. Support for this possibility comes from elegant 
BOLD MRI imaging studies in pregnant subjects showing that maternal hyperoxia does not increase the signal 
in the fetal brain despite an increase in signal in the extra-cranial fetal  organs19. Furthermore, there is evidence 
Figure 4.  Changes in mitochondrial oxidative phosphorylation in the fetal cortex after maternal hyperoxia. 
(A) Representative immunoblots showing all 5 electron transport chain complexes in the cerebral cortical 
homogenates of both male and female offspring after maternal exposure to either room air or hyperoxia, with rat 
heart mitochondria as positive control. Exposure time had to be increased from 1 to 3 min to visualize Complex 
I. (B) Scatter plots highlighting the lack of significant changes in mitochondrial OXPHOS proteins in the fetal 
brain after exposure to 6 h of maternal hyperoxia with 100% oxygen. Data are presented as mean ± S.E.M and 
analyzed with 2-way ANOVA with Sidak’s multiple comparisons test to assess for sex differences in the treated 
group (n = 3 each for all experiments).
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that maternal hyperoxia might directly increase fetal cerebral vascular resistance and redistribute blood flow 
away from the  brain20,21. However, unlike the compromised pups in utero in our study, these imaging studies 
were performed in normoxic fetuses at baseline, which might influence the magnitude and direction of the 
‘brain-sparing’ effect. Finally, humoral responses typically associated with altered vasoreactivity after hyperoxia, 
such as decreased production of nitric oxide and inhibition of endothelial prostaglandin synthesis observed 
in other settings, could be at  play22. Taken together, we are convinced that, unlike the well-characterized fetal 
consequences of maternal hypoxia, the fetal effects of maternal hyperoxia are nuanced and need more targeted 
mechanistic investigations. Nevertheless, we are reassured with the observation that maternal hyperoxia in the 
setting of fetal compromise does not increase oxidative stress biomarkers in the developing brain.
The substantial upregulation of genes related to both the oxidative stress and the antioxidant pathway after 
maternal hyperoxia is a novel finding. We could not ascertain whether the antioxidant response was commensu-
rate with the degree of oxidative stress. However, considering the relatively benign impact of maternal hyperoxia 
on oxidative stress biomarkers, we are inclined to favor the possibility of a proportionate antioxidant response. 
More interesting to us was the sex difference in the oxidative stress response, with male fetuses showing a marked 
upregulation of Nox1 gene, accompanied by a substantial increase in antioxidant enzymes suggestive for a com-
pensatory response. This is perhaps not surprising considering the sex differences in oxidative stress response, 
mitochondrial biology, and gonadal steroid milieu in the developing  brain23–27. For example, females appear to 
have increased intracellular  glutathione28, increased level of the antioxidant paraoxonase  229, and more robust 
mitochondrial biogenesis in males possibly predisposing them to oxidative  stress30. A majority of these changes, 
however, are known to be mediated by estradiol in the post-pubertal brain, so it remains unclear if the hormonally 
neutral intrauterine environment results in such changes in the redox environment of the developing brain. The 
male-specific upregulation of Nox1 (NADPH oxidase 1) warrants further studies because of its integral role as a 
dedicated mammalian enzyme system involved in the generation of superoxide  anions31, a major form of reactive 
oxygen species. Upregulation of Nox1 is widely observed during recovery from ischemic  stroke32–34, suggesting 
that there could be mechanistic parallels between the impact of acute intrapartum ischemia-hypoxemia on the 
fetal brain and ischemic stroke. Future studies are required to determine whether these redox responses are 
persistent and enduring, and whether they lead to functionally variant outcomes in the offspring.
We had previously shown that mitochondrial oxidative phosphorylation was permanently upregulated in the 
cingulate cortex of adolescent male, but not female, rat offspring after uteroplacental ischemia induced by aber-
rant uterine contractility even without maternal  hyperoxia11. Considering the changes in oxidative stress gene 
expression with maternal hyperoxia, we sought to determine if this was accompanied by changes in mitochon-
drial oxidative phosphorylation. Though we limited our investigations to the immediate post-hyperoxia period, 
we did not observe related changes in the expression of proteins from the mitochondrial electron transport chain. 
Whether these sex-dependent changes in oxidative stress gene expression are consequential, enduring, and cause 
altered neurobehavioral outcomes need to be determined.
The biggest strength of the study is that it provides the basic scientific foundation regarding the impact of 
maternal hyperoxia on oxidative stress in the fetal brain. By replicating an acute in utero clinical scenario, our 
study is distinct from other studies in the field that investigate the effect of hypoxia in newborn pups. The only 
comparable study is by Boksa et al. which reported a nuanced effect of oxytocin on redox biology in the fetal 
 brain35, oxytocin increased the lactate levels but reduced the concentration of brain malondialdehyde, an oxida-
tive stress marker. Though reduced oxidative stress may appear to be a counter-intuitive observation, oxytocin 
was administered in this study as a continuous, low-dose infusion which presumably had negligible effects 
on uteroplacental perfusion, and therefore fetal oxidative stress, compared to the acute placental ischemia-
hypoxemia noted with our model. Furthermore, it is unclear whether such changes were caused by oxytocin per 
se or the 6–15 min of induced anoxia at birth that was part of the experimental paradigm. In addition, a direct 
effect of oxytocin could not be ruled out. In contrast, our previously established paradigm clearly demonstrated 
significant uteroplacental ischemia by inducing uterine hypercontractility with a dose of oxytocin that is not 
known to cross the  placenta11,36, resulting in increased confidence in our results.
Our study needs to be interpreted in the context of a few limitations. First, the lack of assessment of blood 
gases in the dam, and therefore, confirmation of maternal hyperoxia, could be cited as a limitation. However, 
previous data from our lab had shown that maternal  PaO2 was approximately 350 mmHg after 4 h of 100% 
oxygen in spontaneously breathing  dams37, providing reassurance that maternal hyperoxia was achieved. The 
more relevant unanswered question was whether maternal hyperoxia was associated with fetal hyperoxia which 
we addressed comprehensively with blood gas studies showing increased partial pressure of oxygen and oxygen 
content in the fetal circulation. Second, our assessment time point of 6 h may have been either too early or too 
late resulting in a failure to capture the magnitude of oxidative stress. However, corroborative evidence suggests 
that biomarkers of oxidative damage such as 4-HNE and protein carbonyl can be detected as early as 1–3 h and 
can be elevated up to 12  h38–41, rendering that possibility unlikely. If 6 h of maternal hyperoxia does not cause 
oxidative damage, it is probably safe to assume that short-term administration of oxygen in the clinical setting is 
unlikely to have a major impact. Third, we did not perform histological analysis of the fetal brain to determine if 
there was neuronal cell death. Though we did not observe neuronal apoptosis after placental ischemia-hypoxemia 
in our previous  study11, direct exposure to 100% oxygen can be neurotoxic to the developing brain especially 
during prolonged or repetitive  exposure42,43, and therefore, needs to be ascertained in future experiments. Third, 
our study does not exclude the possibility of oxidative stress in fetal organs other than the brain. Similarly, a 
brain-region specific change in oxidative stress could not be investigated because of the difficulty in ensuring 
accurate anatomic brain dissection at this developmental age. Finally, the lack of functional neurobehavioral 
outcomes might be considered a limitation, but our study was primarily designed to be a molecular biological 
examination of the developing brain after in utero exposure to maternal hyperoxia.
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In summary, we report that there is no major oxidative damage to the fetal brain after maternal oxygen therapy 
in the setting of intrapartum fetal compromise. Although we noted significant differences in the expression 
of genes in the oxidative stress-mitochondrial oxidative phosphorylation pathway, of which some were sex-
dependent, there were no changes in the expression of emblematic proteins from the mitochondrial oxidative 
phosphorylation pathway. Collectively, our data provide foundational knowledge to better understand the impact 
of the choice of resuscitative agent for fetal distress and raises the biological possibility that sex-specific differ-
ences in neonatal neurological outcomes could potentially be amplified by the choice of maternal resuscitative 
agent. Therefore, follow up studies are required to determine if these gene expression changes are persistent and 
whether they lead to worsening of functional neurobehavioral outcomes.
Materials and methods
All experimental procedures were approved by the Institutional Animal Care and Use Committee at Washington 
University in St. Louis (#20170010) and comply with the Animal Research: Reporting of In Vivo Experiments 
(ARRIVE) guidelines. All methods proposed here were performed in accordance with relevant institutional 
guidelines and regulations.
Animals and treatment. Timed pregnant Sprague–Dawley (SD) rats (SAS 400, Charles River Laborato-
ries, Wilmington, MA) were acquired on embryonic day (E) 13 and housed under standard housing conditions 
until experimentation. On E20, randomized dams were administered 100 mcg/kg oxytocin (OXT) (1 mg/mL in 
sterile normal saline, Selleck Chemicals, Houston, TX) through a 25G tail vein catheter under brief isoflurane 
anesthesia (with compressed 21% oxygen as the carrier gas) to induce a 10 min tetanic uterine contraction and 
acute placental ischemia-hypoxemia as described by us  previously11. In this paradigm, fetal distress was con-
firmed with elevated fetal brain lactate. We chose this dose of OXT because of minimal transplacental  transfer36, 
thereby excluding the possibility of a direct effect of OXT on the developing brain. Following treatment, dams 
were immediately randomly assigned to two groups during the ischemia–reperfusion period: room air (RA) and 
100% oxygen (O). In group RA, treated dams (n = 8) were exposed to 21% oxygen administered at a flow rate of 
3L/min into a standard rat container (Kent Scientific Corporation, Torrington, CT) for 6 h. Similarly, in Group 
O, dams (n = 8) were exposed to 100% oxygen at the same flow rate for 6 h. All containers (3 L total volume) were 
pre-filled with the respective gases at a rate of 5L/min for at least 3 min to reach the satisfied oxygen concentra-
tion. A small outlet in the container allowed for monitoring of gases and prevented buildup of carbon dioxide. 
All dams tolerated the treatment with OXT and the subsequent exposure to different gases. 6 h after either RA 
or O exposure, fetuses were removed via cesarean delivery under brief isoflurane anesthesia (in 21% oxygen for 
group RA and 100% oxygen for group O, respectively, to maintain treatment group-specific oxygen concentra-
tion). Pups were quickly sexed based on differences in anogenital distance between males and females, and both 
male and female brains were extracted and snap-frozen in liquid nitrogen for storage at − 80 °C. One pup of 
either sex was used per treatment condition.
Collection of fetal left ventricular blood for blood gas analysis. To assess whether maternal hyper-
oxia was associated with an increase in fetal oxygenation, we performed a separate set of experiments. Briefly, 6 
E20 timed-pregnant Sprague Dawley dams were administered 100 mcg/kg OXT through a 25G tail vein catheter 
followed immediately by random assignment to either room air or 100% oxygen treatment (n = 3 each) for 6 h as 
described above. Subsequently, at least 3 fetuses were collected per dam via cesarean delivery and immediately 
dissected to access the thoracic cavity. Because left ventricular puncture was technically challenging due to the 
rapid heart rate and the extremely low residence time of blood, we transected the left ventricle, allowed the blood 
to pool in the thoracic cavity, and aspirated it immediately into a heparin-coated 1 mL syringe. We were able 
to collect approximately 100 µL per fetus, and the entire 300 µL from all three fetuses per dam was thoroughly 
admixed in the same syringe before blood gas analysis with the Stat Profile  Prime® Analyzer (Nova Biomedical, 
Waltham, MA).
Assays for biomarkers of oxidative stress. To assess whether exposure to maternal hyperoxia causes 
oxidative damage to the fetal brain, we first assayed for biomarkers of oxidative stress. Specifically, we investi-
gated oxidative damage to lipids (4-hydroxynonenal, a lipid peroxidative product), proteins (protein carbonyl), 
and DNA (8-hydroxy-2′-deoxyguanosine [8-OHdG]) in the brains of both sexes. In addition, we assayed for the 
glutathione (GSSG/GSH) ratio as a marker of the antioxidant response. Approximately 25–50 mg of brain tissue 
from the left cerebral cortex was used for all experiments. Protein concentration was determined using Pierce™ 
BCA Protein Assay Kit (ThermoFisher Scientific). The extent of oxidative damage to lipids and proteins was 
assessed with OxiSelect™ HNE Adduct Competitive ELISA and OxiSelect™ Protein Carbonyl ELISA kits (Cell 
Biolabs), respectively, according to manufacturer’s instructions but with slight modifications (addition of PEI to 
a final concentration of 0.5% for the protein carbonyl assay). 8-OHdG was quantified in specially prepared corti-
cal tissue lysates. Briefly, approximately 25 mg of cortical tissue was homogenized to powder with liquid nitrogen 
using a pestle. DNA was extracted using the DNeasy Blood and Tissue Kit (Qiagen, USA) and the concentration 
was measured using a NanoDrop 2000 spectrophotometer (Thermo Scientific™, USA). Oxidative DNA damage 
marker 8-oxoguanine (8-OHdG) was quantified using the OxiSelect™ Oxidative DNA Damage ELISA kit (Cell 
Biolabs) according to manufacturer’s instructions. Absorbance for all assays was measured at 450 nm. For the 
total glutathione (GSSG/GSH) assay, lysates were prepared with approximately 50 mg of cortical tissue treated 
with 5% metaphosphoric acid followed by quantification with OxiSelect™ Total Glutathione (GSSG/GSH) Assay 
kit (Cell Biolabs) according to manufacturer’s instructions. Absorbance was immediately read at 405  nm at 
1 min intervals for 10 min to determine the slopes for final calculations.
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Taqman RT-qPCR for differential expression of oxidative stress genes. Total RNA was iso-
lated from the right fetal cerebral cortex (approx. 30 mg) using RNeasy Mini Kit (Qiagen, Germantown, MD). 
Genomic DNA was eliminated using QIAshredder (Qiagen, Germantown, MD) and an on-column treatment 
with RNase-Free DNase Set (Qiagen, Germantown, MD). 2.5  µg of purified RNA (260/280 ratio ≥ 2.0) was 
reverse transcribed to cDNA using SuperScript™ IV VILO™ Master Mix with ezDNase™ Enzyme (ThermoFisher 
Scientific, Waltham, MA) in a final volume of 20 μl at 37 °C for 30 min, 50 °C for 10 min, 85 °C for 5 min, 
and 4 °C for 30 min. Subsequently, we performed planned comparisons of treatment-related differences in the 
expression of select target genes related to oxidative stress (Nox1, Nox3, Nos2, Ucp3), antioxidant defense (Cat, 
Gpx1, Gpx4, Gsr, Prdx1, Prdx2, Prdx3, Prdx6, Sod1, Sod2, Sod3, Srxn1, Cygb, Ngb, Txnip, Txnrd2), and the mito-
chondrial electron transport chain (ETC) (Mt-cyb, Mt-nd1, Mt-nd2, Mt-nd4, Mt-nd5, Mt-atp8, Mt-co1, Mt-co3). 
We included mitochondrial ETC genes because of the integral role of mitochondria in the generation of reactive 
oxygen species during oxidative stress. A customized TaqMan Array 96-well FAST plate (ThermoFisher Scien-
tific, Waltham, MA) containing these 28 prevalidated probes and 4 endogenous genes (18S rRNA, Actb, Gapdh, 
Pgk1) was used for qPCR. Each 10 μl reaction contained 5 μl of TaqMan Master Mix (ThermoFisher Scientific, 
Waltham, MA), 3μL of ultrapure water, and 2  μl of cDNA. qPCR was performed in an Applied Biosystems 
7500 Real-Time PCR System (ThermoFisher Scientific, Waltham, MA) with the following cycling conditions: 
preincubation at 50 °C for 2 min and then at 95 °C for 10 min, followed by 40 amplification cycles (95 °C, 15 s 
and 60 °C, 1 min) and cooling (40 °C, 10 s). All reactions were performed in triplicate. Of the 4 endogenous 
reference genes, only Actb and Gapdh were stably expressed across experimental conditions (geNorm algorithm; 
qbase + version 3.2). Relative mRNA expression, normalized to the geometric mean of Actb and Gapdh, was 
calculated using the  2−ΔΔCT method with sex-matched control samples as reference.
Western blot for mitochondrial oxidative phosphorylation. Next, we performed immunoblots of 
the developing cortex to quantify the effect of maternal oxygen resuscitation on the mitochondrial oxidative 
phosphorylation system (OXPHOS) in the developing brain. Briefly, we isolated mitochondria from approxi-
mately 100 mg of the fetal cortex using the Mitochondria Isolation Kit (ThermoFisher Scientific) followed by 
lysis and homogenization with RIPA buffer containing protease inhibitor and phosphatase inhibitor in 1X PBS. 
Protein concentrations were determined using a BCA protein assay kit (ThermoFisher Scientific, USA). 15 µg 
of each sample was treated with reduced LDS buffer and heated at 50 °C for 5 min, then loaded onto a 10% Bolt 
gel (ThermoFisher Scientific). Rat heart mitochondria was used as positive control. After separation in MES 
SDS running buffer (ThermoFisher Scientific), proteins were transferred to nitrocellulose membrane and sub-
sequently blocked for 2 h at room temperature in 5% non-fat dry milk and 1X Tween 20 in Tris-buffered saline 
(TBS-T). Membrane was incubated with primary mouse anti-OXPHOS antibody (OriGene; 1:3000 diluted in 
5% BSA and 1X TBS-T) overnight at 4 °C, followed by HRP-conjugated anti-mouse secondary antibody (1:5000 
diluted in 5% non-fat dry milk and 1X TBS-T) for 1 h at room temperature. A chemiluminescent detection 
reagent (ECL Prime, GE Healthcare) was used to visualize the proteins. After stripping for 45 min followed by 
blocking with 5% non-fat dry milk and 1X TBS-T for 30 min, the membrane was reprobed with rabbit anti-
VDAC1 antibody (Cell Signaling, US. 1:5000 diluted in 5% non-fat dry milk and 1X TBS-T) for 1 h at room 
temperature, followed by HRP-conjugated anti-rabbit secondary antibody (1:5000 diluted in 5% non-fat dry 
milk and 1X TBS-T) for 1 h at room temperature. Images were subsequently processed with Image Studio ver 
5.2 (LI-COR) for densitometric quantification. Full-length western blot images are presented as Supplementary 
Information.
Statistical analysis. Data outliers were detected and eliminated using ROUT (robust regression and out-
lier analysis) with Q set to 10%. Normality of residuals was checked with D’Agostino-Pearson omnibus test 
followed by Welch’s t-test for blood gas data and the 2-way ANOVA and Sidak’s multiple comparisons test for 
all other data where sex of the offspring was a variable. RT-qPCR data with non-normal residuals (Nox1, Nos2, 
Prdx3, Sod3, Srxn1, Mt-atp8, Mt-co3) were Box-Cox transformed prior to statistical testing. Data are presented 
as mean ± SEM and analyzed with Prism 8 for Mac OS X (Graphpad Software, Inc, La Jolla, CA). A two-tailed P 
value ≤ 0.05 was accorded statistical significance.
Conference presentation. This abstract was presented at the 40th Annual Pregnancy Meeting, Society for 
Maternal Fetal Medicine, Grapevine, TX, 76501, February 3–8, 2020.
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